Mirna Therapeutics reports 3Q loss

AUSTIN, Texas (AP) _ Mirna Therapeutics Inc. (SYBX) on Monday reported a loss of $11.9 million in its third quarter.

On a per-share basis, the Austin, Texas-based company said it had a loss of $1.66.

The biopharmaceutical company posted revenue of $111,000 in the period.

Mirna Therapeutics shares have declined 21 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $10, a climb of 14 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SYBX at https://www.zacks.com/ap/SYBX